NCT05158478View on ClinicalTrials.gov

Hematocrit Effect on a Blood Glucose Monitor

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

February 22, 2022

Primary Completion Date

February 22, 2022

Study Completion Date

March 14, 2022

Conditions
Diabetes Mellitus
Interventions
DIAGNOSTIC_TEST

blood glucose measurement, blood glucose monitor for personal use

measurement of the blood glucose concentration using the blood glucose monitor for personal use (TJ100)

DIAGNOSTIC_TEST

blood glucose measurement, laboratory reference device

measurement of the blood glucose concentration using a laboratory reference device (YSI 2300 Stat Plus)

Trial Locations (1)

17495

Institut für Diabetes Karlsburg GmbH, Karlsburg

All Listed Sponsors
collaborator

Tyson Bioresearch Inc., Kedong 3rd Rd., Zhunan Township, Miaoli County 35053, Taiwan

UNKNOWN

lead

Institut fur Diabetes Karlsburg GmbH

OTHER